IMM PE invites potential buyers for Genuone worth $752 mn

South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...
South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...
IMM Private Equity has put a South Korean contract drugmaker on the market for up to 1 trillion won ($784 million) in a deal likely to attract major...